⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT April 20, 2026

Sitagliptin/Metformin 1A Pharma 50 mg/850 mg – Filmtabletten 50 mg/850 mg (Filmtablette)

📷 Wikipedia: Metformin · Source
Sitagliptin/Metformin 1A Pharma 50 mg/850 mg – Filmtabletten 50 mg/850 mg (Filmtablette)
📷 Wikipedia: Metformin · Source
Parallel export is banned for Sitagliptin/Metformin 1A Pharma 50 mg/850 mg film-coated tablets due to manufacturing capacity shortages.
⚠️
Shortage ongoing
METFORMIN HYDROCHLORID is currently in short supply in AT.
📈 Timeline
10 days active so far
May 18, 2026 May 27, 2026

What is this? This is a pill that combines two medicines, metformin and sitagliptin. It helps control blood sugar in people with diabetes.

What's happening? The company cannot make enough of these pills right now. They ran out in Austria on 20 April 2026.

Does this affect me? If you take this exact pill in Austria, you may not be able to get more when your supply runs out.

What should I do? Talk to your pharmacist or doctor about other medicines you can use instead.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Agency-published detail

🚫 Parallel export ban active · ATC: A10BD07 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: 1 A Pharma GmbH, Jakov-Lind-Straße 5/3.05, 1020 Wien, Österreich · Affected packs: 60 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-04-20]

First published
April 20, 2026
Last refreshed by us
15 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

High AT 3 weeks ago

Sitagliptin/Metformin Sandoz 50 mg/850 mg – Filmtabletten 50/850 mg/mg (Filmtablette)

Sitagliptin/Metformin Sandoz 50 mg/850 mg film-coated tablets are subject to a parallel export ban. Supply is restricted due to manufacturing capacity shortages.
High AT 1 month ago

Sitagliptin 1A Pharma 100 mg – Filmtabletten 100 mg (Filmtablette)

Sitagliptin 1A Pharma 100 mg film-coated tablets are unavailable due to manufacturing shortages.
High AT 3 months ago

Sitagliptin +pharma 25 mg Filmtabletten 25 mg (Filmtablette)

Sitagliptin +pharma 25 mg film-coated tablets are no longer available since 16 February 2026 and will be restocked on 1 June 2026.
High AT resolved 3 months ago

Sitagliptin 1A Pharma 25 mg – Filmtabletten 25 mg (Filmtablette)

Sitagliptin 1A Pharma 25 mg film-coated tablets are unavailable due to manufacturing shortages.
High AT 5 months ago

Metformin ratiopharm 1000 mg Filmtabletten 1000 mg (Filmtablette)

Metformin ratiopharm 1000 mg film-coated tablets are delayed. Affected packs: 60-tablet box and blister pack, unavailable since 18 December 2025; 20-tablet box and blister pack, unavailable since 20 F...

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Sitagliptin/Metformin 1A Pharma 50 mg/850 mg – Filmtabletten 50 mg/850 mg (Filmtablette). Parallel export is banned for Sitagliptin/Metformin 1A Pharma 50 mg/850 mg film-coated tablets due to manufacturing capacity shortages.
▸ When was this alert issued?
This alert was issued on April 20, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.